![Whittemore Tingley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 187 267 $ am 31.05.2026
Whittemore Tingley is Chief Medical Officer at Tenaya Therapeutics, Inc. since 2018.
Former positions include Group Medical Director at Genentech, Inc. from 2009 to 2017, Vice President-Clinical Development & Cardiology at Cytokinetics, Inc. from 2017 to 2018, and Group Medical Director at Roche Holding AG.
Education includes undergraduate studies at Brown University and a doctorate from The Johns Hopkins University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 215 497 ( 0,1 % ) | 187 267 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 |
| ROCHE HOLDING AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
